Enhanced Expression of CD47 Is Associated With Off-Target Resistance to Tyrosine Kinase Inhibitor Gefitinib in NSCLC

Mutual interactions between cancer cells and the tumor microenvironment importantly contribute to the development of tyrosine kinase inhibitor (TKI) resistance in patients affected by EGFR-mutant NSCLC. In particular, immune recognition-associated proteins with impact on tumor cell clearance through...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Nigro, Annunziata, Ricciardi, Luca, Salvato, Ilaria, Sabbatino, Francesco, Vitale, Monica, Crescenzi, Maria Assunta, Montico, Barbara, Triggiani, Massimo, Pepe, Stefano, Stellato, Cristiana, Casolaro, Vincenzo, Dal Col, Jessica
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7004973/
https://ncbi.nlm.nih.gov/pubmed/32082304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.03135
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados